Biotech Connection Singapore
  • Home
  • About Us
    • About BCS
    • Executive Committee
    • Advisors
    • Alumni
  • Events
    • Past Events
  • Consulting
    • Consulting
    • Singapore Life Science Case Competition
    • BCS Report –the Singapore Biotech Landscape
  • Communications
    • Academics to Industry
    • Career Series
    • COVID-19
    • Investment
    • Legal
    • Interviews
    • Emerging Industry Trends
    • Industry Practices
    • Research Methods
  • Jobs
  • Contact
  • Videos

Industry Practices

Communications

Nailing Your Recombinant Antibody Project

In this article, Dr. Leung How Wing and Dr. Luan Bowu from GenScript explain important considerations for optimal recombinant antibody production.

By Biotech Connection Singapore, 1 yearNovember 11, 2021 ago
Communications

Manufacturing small molecules, biologics and cell therapy products for first-in-human trials

How should you manufacture your drug for clinical use? We look at recommended strategies for small molecules, antibodies, and cell therapy. Contributed by: David T. J. Loong

By Biotech Connection Singapore, 3 yearsMarch 1, 2020 ago
Communications

General considerations for manufacturing experimental medicines for first-in-human clinical trials

Getting ready to test your drug, antibody, or cell therapy in humans? Here are some general points to consider! Contributed by: David T. J. Loong

By Biotech Connection Singapore, 3 yearsFebruary 23, 2020 ago
For queries about Biotech Connection Singapore, its consulting service and articles, please email:info@biotechconnection-sg.org

Logo - Colour

Copyright© 2020, Biotech Connection Singapore. All Rights Reserved
  • Home
  • People
  • Events
  • Communications
  • Consulting
  • Contact
  • Home
Hestia | Developed by ThemeIsle

The BCS Landscape Report Dismiss